Roundup Cancer Lawsuit News

Economic Damage From The Coronavirus Economic Shutdown Could Impact Bayer Monsanto Cancer Settlement Talks

Pricing and liquidating assets to create funds to pay future cancer claims is nearly impossible until the dust settles on reopening the economy

Monday, May 11, 2020 - With the economy already in a deep recession and suffering from depression unemployment numbers, negotiators in the Bayer Monsanto cancer trials do not see a clear current path forward. reports that settlement talks have been put on hold for the foreseeable future until there is a clearer picture of stock and real estate prices and the liquidity there will be in the financial marketplace. Bayer is looking to streamline its settlement offer to include potentially hundreds of thousands in future claims over the next ten to twenty years.

Non-Hodgkin's lymphoma has a latency period of ten or more years until symptoms become apparent and treatment sought. Farmers, landscapers, maintenance workers, and others continue to use the herbicide every day as few US bans have been put in place other than a municipality here and there. Bayer attorneys are paralyzed due to the uncertainty over what the economy and demand will look like when the country eventually re-opens and if they will be faced with a liquidity crisis. Bayer told Fortune: "Against the background of a looming recession and looking at, in part, considerable liquidity challenges, this applies now more than ever." Bayer is said to have allocated roughly $10 - $20 million to settle claims from then only around 12,000 plaintiffs represented in large groups by a handful of lawyers. Bayer fears that the company would now be forced to liquidate assets at the worst possible time to set aside funds for future claims that could be in the hundreds of billions of dollars.

It probably comes as no surprise that Roundup herbicide and genetically modified foods are being blamed for causing the complications that are appearing in victims of the Coronavirus. As of the end of February 2020, more than 52,000 people have filed for compensation from the injuries they have allegedly suffered from using Roundup herbicide and getting the chemical on their skin repeatedly and developing non-Hodgkin's lymphoma, a rare form of cancer of the lymph nodes. 2020 Bayer Roundup Cancer trials have been put on hold for the time needed to work out a settlement that doesn't look any more certain than it did when the negotiations began. Over the last couple of years, Bayer Monsanto has lost three out of three trials costing the company nearly $200 million.

Individuals that work in an occupation where they regularly spray Roundup herbicide such as government grounds maintenance are urged to seek the guidance of a Bayer / Monsanto cancer attorney to see if they qualify to file a lawsuit. Many have claimed that the company knew that Roundup was carcinogenic and did little to warn consumers. If you or a loved one have been diagnosed with cancer and you may wish to consult with a Monsanto Roundup Herbicide attorney.

More Recent Roundup Cancer Lawsuit News:

Lawyers for Roundup Cancer Lawsuits

Attorneys handling Roundup cancer lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Roundup cancer lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Roundup cancer lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.